Structural basis for the antiproliferative activity of the Tob-hCaf1 complex

Masataka Horiuchi1, Kosei Takeuchi, Nobuo Noda

  • 1Department of Structural Biology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Insights

The Tob protein complex with human Caf1 (hCaf1) inhibits cell growth. Complex formation, not deadenylase activity, is key for Tob/hCaf1

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Cell Biology

Background:

  • Tob/BTG proteins are antiproliferative factors.
  • They interact with CCR4-associated factor 1 (Caf1), a deadenylase component of the CCR4-Not complex.

Purpose of the Study:

  • Determine the crystal structure of the Tob N-terminal region complexed with human Caf1 (hCaf1).
  • Investigate the role of Caf1's deadenylase activity versus complex formation in Tob-mediated cell growth inhibition.

Main Methods:

  • X-ray crystallography to determine the structure of the Tob-hCaf1 complex.
  • Cell growth assays using wild-type and mutant proteins.

Main Results:

  • The crystal structure revealed a novel fold for Tob and similarity of hCaf1 to known catalytic domains.
  • hCaf1 association with Tob is mediated by both Box A and Box B regions.
  • Cell growth inhibition by Tob/hCaf1 depends on complex formation, not Caf1's deadenylase activity.

Conclusions:

  • Caf1 acts as a tether, bringing Tob to the CCR4-Not complex.
  • Tob, via its C-terminal region, recruits factors like poly(A)-binding proteins to inhibit cell proliferation.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...